Two Sigma Advisers’s Atossa Therapeutics ATOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,220
| Closed | -$10.8K | – | 199 |
|
|
2025
Q4 | $10.8K | Buy |
+1,220
| New | +$15.4K | ﹤0.01% | 2324 |
|
|
2025
Q3 | – | Sell |
-2,280
| Closed | -$28.4K | – | 2356 |
|
|
2025
Q2 | $28.4K | Sell |
2,280
-1,513
| -40% | -$18.1K | ﹤0.01% | 2284 |
|
|
2025
Q1 | $38.3K | Buy |
3,793
+966
| +34% | +$11.7K | ﹤0.01% | 2332 |
|
|
2024
Q4 | $40K | Buy |
2,827
+1,927
| +214% | +$37.6K | ﹤0.01% | 2298 |
|
|
2024
Q3 | $20.5K | Sell |
900
-2,713
| -75% | -$54.8K | ﹤0.01% | 2252 |
|
|
2024
Q2 | $64.5K | Buy |
3,613
+2,380
| +193% | +$52.7K | ﹤0.01% | 2347 |
|
|
2024
Q1 | $33.3K | Sell |
1,233
-447
| -27% | -$7.18K | ﹤0.01% | 2372 |
|
|
2023
Q4 | $22.2K | Buy |
1,680
+260
| +18% | +$2.81K | ﹤0.01% | 2444 |
|
|
2023
Q3 | $15.7K | Sell |
1,420
-407
| -22% | -$5.9K | ﹤0.01% | 2332 |
|
|
2023
Q2 | $34.5K | Sell |
1,827
-2,226
| -55% | -$27K | ﹤0.01% | 2296 |
|
|
2023
Q1 | $44.1K | Sell |
4,053
-2,054
| -34% | -$22.9K | ﹤0.01% | 2464 |
|
|
2022
Q4 | $48.4K | Sell |
6,107
-920
| -13% | -$10.6K | ﹤0.01% | 2367 |
|
|
2022
Q3 | $88K | Sell |
7,027
-1,460
| -17% | -$21.2K | ﹤0.01% | 2325 |
|
|
2022
Q2 | $139K | Sell |
8,487
-36,953
| -81% | -$582K | ﹤0.01% | 2346 |
|
|
2022
Q1 | $852K | Sell |
45,440
-61,089
| -57% | -$1.24M | ﹤0.01% | 1722 |
|
|
2021
Q4 | $2.56M | Buy |
106,529
+100,662
| +1,716% | +$3.68M | 0.01% | 1068 |
|
|
2021
Q3 | $287K | Buy |
5,867
+3,300
| +129% | +$192K | ﹤0.01% | 2132 |
|
|
2021
Q2 | $243K | Sell |
2,567
-660
| -20% | -$34.9K | ﹤0.01% | 2212 |
|
|
2021
Q1 | $102K | Buy |
3,227
+2,507
| +348% | +$91.6K | ﹤0.01% | 2440 |
|
|
2020
Q4 | $10K | Sell |
720
-93
| -11% | -$2.15K | ﹤0.01% | 2356 |
|
|
2020
Q3 | $30K | Buy |
+813
| New | +$39K | ﹤0.01% | 2349 |
|
Other funds holding ATOS
VCM
VFT
